Nasdaq approves listing of Bio-key
21 July 2017 13:43 GMT

Biometric firm Bio-key announced today that its Common Stock has been approved for listing on the Nasdaq Capital Market, effective with the start of trading on Tuesday, July 25, 2017. BIO-key's shares will continue to trade under the symbol BKYI.

Michael DePasquale, Chairman & CEO of BIO-key, commented, "Our Nasdaq listing is a significant milestone for BIO-key and our shareholders, that underscores our ramping sales momentum so far this year. We continue to see growing interest in the efficiency, cost benefits and enhanced security of our biometric solutions. This trend is supported by the growing prevalence of fingerprint biometric solutions on mobile devices as well as the recognition that conventional password and PIN authentication is fundamentally broken.

"Innovation is also playing a pivotal role in expanding BIO-key's business potential. We continue to develop new technology to solve pressing, large-scale cybersecurity and authentication challenges as well as consumer-facing products that leverage our core biometric expertise. "

Mr. DePasquale added, "In addition to providing a range of benefits to our shareholders, we believe listing on Nasdaq will also support our sales and marketing momentum by raising the visibility of our brand and authentication solutions before prospective customers, partners and the media."

BIO-key was advised by Maxim Group LLC and Donohoe Advisory Associates LLC in its Nasdaq listing process.